SCHEMBL6022443

SCHEMBL6022443

CC/N=N\NCC.[KH].[KH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6022449 1.00
SCHEMBL2299224 0.97
SCHEMBL2299226 0.97
SCHEMBL734083 0.69
SCHEMBL8710940 0.67
SCHEMBL806037 0.67
SCHEMBL24012074 0.65
SCHEMBL8906564 0.65
SCHEMBL2669902 0.65
SCHEMBL14616040 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023057354-A1 WOUND DRESSING COMPOSITIONS AND METHODS OF USE AND PREPARATION THEROF T.J.SMITH AND NEPHEW,LIMITED (GB) 2023-04-13 WO disclosed
EP-1677718-A2 TREATMENT OF OVERUSE TENDINOPATHY USING TRANSDERMAL NITRIC OXIDE-GENERATING AGENTS NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY (US) 2006-07-12 EP disclosed
WO-2005037347-A2 TREATMENT OF OVERUSE TENDINOPATHY USING TRANSDERMAL NITRIC OXIDE-GENERATING AGENTS NEW YORK SOCIETY FOR THE RUPTURED AND CRIPPLED MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY (US) 2005-04-28 WO disclosed